Autoimmune polyglandular syndrome type 2

Keywords

Autoimmune polyglandular syndrome
adrenal insufficiency
hypothyroidism
autoimmune diseases
vitiligo
hypogonadism

How to Cite

Rojas-Garcia, W. ., Tovar-Cortes, H. ., Gonzalez Calderon, M. C., Ospino Guerra, M. C. ., & Herrera-Parra, A. M. . (2026). Autoimmune polyglandular syndrome type 2. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 13(3). https://doi.org/10.53853/encr.13.3.986

Abstract

Introduction: Autoimmune polyglandular syndrome type 2 (APS-II) is a rare disorder characterized by the coexistence of primary adrenal insufficiency with autoimmune thyroid disease and/or type 1 diabetes mellitus. It may also be associated with other endocrine and non-endocrine autoimmune conditions.

Objective: To report a clinical case of autoimmune polyglandular syndrome type 2 and highlight the importance of its timely recognition in clinical practice.

Case presentation: A 33-year-old woman with a history of autoimmune hypothyroidism and vitiligo presented with constitutional symptoms and cutaneous manifestations. Evaluation revealed adrenal crisis, hypergonadotropic hypogonadism, the presence of positive antithyroid antibodies, and thyroid dysfunction, findings consistent with APS-II. Treatment with glucocorticoids, mineralocorticoids, and hormone replacement therapy was initiated, with progressive clinical improvement.

Discussion: Autoimmune polyglandular syndrome type 2 is a challenging diagnosis due to its heterogeneous and progressive presentation. A high index of suspicion is required, especially in patients with multiple autoimmune conditions. The combination of clinical manifestations and hormonal studies allows for diagnosis and guides appropriate treatment. Although less common, hypergonadotropic hypogonadism may occur as part of the clinical spectrum.

Conclusion: This case underscores the importance of considering autoimmune polyglandular syndrome type 2 in patients with multiple autoimmune diseases. Early diagnosis enables appropriate treatment and helps prevent serious complications. Additionally, it contributes to raising awareness of this condition in Colombia, where reports remain scarce.

https://doi.org/10.53853/encr.13.3.986

References

Frommer?L, Kahaly?GJ. Autoimmune Polyendocrinopathy. Journal of Clinical Endocrinology & Metabolism. 2019;104(10):4769–4782. doi:?10.1210/jc.2019-00602

Kahaly?GJ, Frommer?L. Polyglandular autoimmune syndromes. Journal of Endocrinological Investigation. 2018;41(1):91–98. doi:?10.1007/s40618-017-0740-9

Husebye?ES, Anderson?MS, Kämpe?O. Autoimmune Polyendocrine Syndromes. New England Journal of Medicine. 2018;378(12):1132–1141. doi:?10.1056/NEJMra1713301

Fernández?Miró?M, Colom?Comí?C, Godoy?Lorenzo?R. Autoinmune polyendocrinopathy. Síndromes pluriglandulares autoinmunes. Medicina Clínica. 2021;157(5):241–246. doi:?10.1016/j.medcle.2021.08.006

Michels?AW, Gottlieb?PA. Autoimmune polyglandular syndromes. Nature Reviews Endocrinology. 2010;6(5):270–277. doi:?10.1038/nrendo.2010.40

Cutolo?M. Autoimmune polyendocrine syndromes. Autoimmunity Reviews. 2014;13(2):85–89. doi:?10.1016/j.autrev.2013.07.006

Kahaly?GJ. Polyglandular autoimmune syndrome type II. Presse Médicale. 2012;41(12?Pt?2):e663–e670. doi:?10.1016/j.lpm.2012.09.011

Betterle?C, Lazzarotto?F, Presotto?F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clinical and Experimental Immunology. 2004;137(2):225–233. doi:?10.1111/j.1365-2249.2004.02561.x

Fortich?Revollo?AJ, Mora?García?G, Fortich?Salvador?A, et?al. Síndrome poliglandular autoinmune tipo II en el Hospital Universitario del Caribe, Cartagena, Colombia. Revista Ciencias Biomédicas. 2011;2(1):54–62. doi:?10.32997/rcb-2011-3386

Zuluaga?Sepúlveda?MA, Jiménez?Tamayo?SB. Síndrome poliglandular autoinmune asociado a vitiligo. CES Med. 2013;27(2):227–233. DOI no disponible

Szeliga?A, Calik?Ksepka?A, Maciejewska?Jeske?M, et?al. Enfermedades autoinmunes en pacientes con insuficiencia ovárica prematura: nuestro estado actual del conocimiento. International Journal of Molecular Sciences. 2021;22(5):2594. doi:?10.3390/ijms22052594

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2026 Revista Colombiana de Endocrinología, Diabetes & Metabolismo

Dimensions


PlumX


Downloads

Download data is not yet available.